Health & Therapy

As psilocybin and MDMA move deeper into psychiatric research and clinical practice, the conversation is shifting from therapeutic promise towards...

For much of the past decade, the psychedelic industry has revolved around companies developing the drugs themselves. Psilocybin, MDMA, LSD...

Ensysce Biosciences will participate in the U.S. Food and Drug Administration's September 14 public hearing on the potential future therapeutic...

As Australia looks back on National Pain Week, held from 26–31 July, attention remains focused on one of the country's...

For more than half a century, psychiatry has focused primarily on the brain. Depression, anxiety, post-traumatic stress disorder, and other...

Beyond SSRIs lies a global battle between pharma, therapy, technology, and the future of human consciousness. For decades, modern psychiatry...

The Quiet Battle Defining a $10 Billion Industry Psychedelic therapy is not just being approved. It is being defined. Behind...